KCNMA1 and glioblastoma: The glioblastoma cell line DBTRG-05MG with the BRAFV600E mutation [70, 71] showed high levels of both p-BRAF and KCNMA1 with a correspondingly hyper-activated BRAF/MAPK pathway.